GRAIL to Present at the 2026 Jefferies Global Healthcare Conference
GRAIL (Nasdaq: GRAL) announced that management will present at the 2026 Jefferies Global Healthcare Conference in New York on Wednesday, June 3, 2026 at 7:35 a.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
GRAIL (Nasdaq: GRAL) announced that management will present at the 2026 Jefferies Global Healthcare Conference in New York on Wednesday, June 3, 2026 at 7:35 a.m. ET.
Live and replay webcasts will be available in the investor relations section of GRAIL's website for at least 30 days.
Details
News Market Reaction – GRAL
On May 22, the first trading day after this news, GRAL closed 0.99% below the previous close.
Data tracked by StockTitan Argus for the May 22 session.
Key Figures
- Conference date
- June 3, 2026
- Jefferies Global Healthcare Conference presentation
- Presentation time
- 7:35 a.m. ET
- Scheduled start time for conference presentation
- Webcast archive duration
- 30 days
- Replay available in investor relations section
Historical Context
-
Reported revenue and Galleri growth with improved loss metrics.
-
Announced BofA Securities 2026 Health Care Conference presentation.
-
Set timing for first quarter 2026 results and webcast details.
-
Planned presentation of late-breaking NHS-Galleri and PATHFINDER 2 results.
-
Announced Galleri test integration into Epic EHR for broad access.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Live and replay webcasts may be accessed in the investor relations section of GRAIL's website at investors.grail.com. The webcast will be archived and available for reply for at least 30 days after the event.
About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in
For more information, visit grail.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-to-present-at-the-2026-jefferies-global-healthcare-conference-302779216.html
SOURCE GRAIL, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.